Palliative use of midazolam in acute geriatric units: a multicenter ambispective study.

ABSTRACT:

Introduction

End-of-life management in acute geriatric units (AGUs) is frequent but complex. Midazolam is the drug of choice for the management of refractory symptoms (particularly in the context of sedation) at the end of life. The objective of the present ambispective analysis was to investigate the frequency and modalities of midazolam use for palliative care in AGUs in France.

Methods

We conducted a prospective study in four AGUs in France, in order to identify patients having received comfort care only and having been treated with midazolam. We then retrospectively documented the modalities of midazolam use, the indications, and the level of effectiveness.

Results

Of the 210 patients identified as having received comfort care only in the AGU, 68 (32.4% (95%CI, 26

SUBMITTER: Prod'homme C 

PROVIDER: S-EPMC11983973 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature